Global Immunotherapy in Oncology Startup Identification Report 2020: Over 110 Startups Working in the Field of Onco-Immunotherapy
15 sept. 2020 05h43 HE
|
Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Immunotherapy in Oncology Startup Identification" report has been added to ResearchAndMarkets.com's offering. Cancer Immunotherapy is a very dynamic...
Notable Launches The ANSWer Study: An Observational Clinical Trial for Patients with Blood Cancer and Enrolls First Patients
22 janv. 2020 09h14 HE
|
Notable Labs
SAN FRANCISCO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling...
In Personalized Medicine Feasibility Study, Stanford Medical Center, With Partners Notable and Tempus, Able to Make Rapid Personalized Treatment Recommendations for 100 Percent of Blood Cancer Patients
15 avr. 2019 13h38 HE
|
Notable Labs
SAN FRANCISCO, April 15, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated AI platform that rapidly advances cancer drug development at a fraction of...
Oncology Startup Notable Expands Leadership Team With New Chief Medical and Chief Development Officers
25 févr. 2019 11h00 HE
|
Notable Labs
FOSTER CITY, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction...